Your browser doesn't support javascript.
loading
New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy.
Zarrabi, Kevin; Fang, Chunhui; Wu, Shenhong.
Affiliation
  • Zarrabi K; Department of Medicine, Stony Brook University Hospital, 9447 Suny, Stony Brook, NY, 11794-9447, USA.
  • Fang C; Department of Medicine, Stony Brook University Hospital, 9447 Suny, Stony Brook, NY, 11794-9447, USA.
  • Wu S; Department of Medicine, Stony Brook University Hospital, 9447 Suny, Stony Brook, NY, 11794-9447, USA. Shenhong.Wu@Stonybrookmedicine.edu.
J Hematol Oncol ; 10(1): 38, 2017 02 02.
Article in En | MEDLINE | ID: mdl-28153029
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Angiogenesis Inhibitors / Therapies, Investigational / Kidney Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Angiogenesis Inhibitors / Therapies, Investigational / Kidney Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Country of publication: